Palomino Laboratories (PALX) Non-Current Debt (2022 - 2024)
Palomino Laboratories (PALX) posted Non-Current Debt of $13750.0 for Q3 2024, up 10.0% sequentially from $12500.0 in Q2 2024, and up 57.14% YoY from $8750.0 in Q4 2023.
Palomino Laboratories (PALX) Non-Current Debt (2022 - 2024) Analysis & Trends
Palomino Laboratories has reported Non-Current Debt for 3 years, with the latest figure at $13750.0 in Q3 2024.
- Quarterly Non-Current Debt rose 57.14% year-over-year to $13750.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $13750.0 (up 57.14% YoY) and the FY2023 annual result came in at $10000.0, up 100.0% from the prior year.
- Non-Current Debt rose to $13750.0 in Q3 2024 per PALX's latest filing, from $12500.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $13750.0 in Q3 2024 and troughed at $5000.0 in Q4 2022.
- A 3-year average of $10208.3 and a median of $10625.0 in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt jumped 100.0% in 2023, then soared 57.14% in 2024.
- Over 3 years, Non-Current Debt stood at $5000.0 in 2022, then surged by 100.0% to $10000.0 in 2023, then jumped by 37.5% to $13750.0 in 2024.
- According to Business Quant data, Non-Current Debt over the past three periods registered $13750.0, $12500.0, and $11250.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 13,750.00 |
| Jun 30, 2024 | 12,500.00 |
| Mar 31, 2024 | 11,250.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 8,750.00 |
| Dec 31, 2022 | 5,000.00 |